AskBio in the News
As a world-leading gene therapy company, we are continuously advancing AAV therapeutics, discovering new technology, forging new research collaborations, and adding amazing talent to our team.
AskBio Enters Research Collaboration and Licensing Agreement with University of North Carolina (UNC) for Angelman Syndrome
Tim Kelly Joins AskBio as President of Manufacturing to Lead AAV Vector Production for Gene Therapy
CYTOO and AskBio Enter into Research Agreement to Screen Gene Therapy Candidates for Rare Muscle Disorder
AskBio Appoints Anna Tretiakova, PhD, as Senior Vice President of Product Development
AskBio Announces First Patient Dosed in Phase 1 Trial Using AAV Gene Therapy for Congestive Heart Failure
AskBio Launches AskFirst™ Patient Advocacy Program to Educate and Support Participants in Gene Therapy Clinical Trials
AskBio To Present At The 38th Annual J.P. Morgan Healthcare Conference
AskBio Licenses Rights to Selecta Biosciences’ ImmTOR™ Immune Tolerance Platform for the Treatment of Pompe Disease
AskBio Receives “Best Venture Funding” Award from Southeast BIO
SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies
Sheila Mikhail, AskBio CEO and Cofounder, Named Springboard Enterprises’ 2019 Northstar Honoree
Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Viralgen Receives cGMP Certification from European Medicines Agency
AskBio Applauds Pfizer’s Continuing Investments in Gene Therapy
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Selecta Biosciences Combines ImmTOR™ Platform with AskBio’s IndustryLeading Gene Therapy Platform in Strategic Partnership
Statement: Pfizer Phase 1b Clinical Trial Results
Newly Approved Spinal Muscular Atrophy Gene Therapy, Zolgensma®, Validates AskBio Gene Therapy Platform
AskBio Partners with TPG and Vida Ventures
First Patient Dosed with Gene Therapy in Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease
Asklepios BioPharmaceutical, Inc. Launches New Portfolio Company – Actus Therapeutics, Inc.
AskBio and Columbus Venture Partners Launch Gene Therapy Company Viralgen
NanoCor Announces New Data on Congestive Heart Failure Gene Therapy
Pfizer Aims To Become Industry Leader In Gene Therapy With Acquisition Of Bamboo Therapeutics, Inc.
Baxter to Acquire Chatham Therapeutics
Asklepios BioPharmaceutical Enters Into A Patent License Agreement With Pfizer
Medtronic Makes Equity Investment in NanoCor Therapeutics, Inc.
AskBio, UNC Team Up to Develop Gene Therapy for Angelman Syndrome
WRAL Techwire
March 24, 2020
Big Pharma Shied Away from Gene Therapy for Years. Academia Picked Up the Slack.
BioPharma Dive
March 17, 2020
Tim Kelly Joins AskBio as President of Manufacturing
Manufacturing Chemist
March 13, 2020
What’s Holding Back Gene Therapy?
MedPage Today
February 19, 2020
AskBio Initiates Phase I Trial of Gene Therapy for Heart Failure
Clinical Trials Arena
February 5, 2020
AskFirst: AskBio’s New Gene Therapy Program for Clinical Trial Patients
WRAL TechWire
February 3, 2020
What Duke University Has in Common with Yale, UC Berkeley
Triangle Business Journal
January 6, 2020
Top 10 Young Companies in the Money 2019
GEN Engineering News
January 6, 2020
Triangle-based AskBio to Pay up to $240M for Rights to Use Gene Therapy Technology
WRAL TechWire
December 19, 2019
A New Pair of Genes
NC Economic Development Guide | Business North Carolina
December 16, 2020
2020: New Decade, New Disruption: Cell and Gene Therapy to Eradicate Genetic Diseases
Medical Expo
December 3, 2019
SQZ Biotech and AskBio Collaborate to Overcome AAV Immunogenicity
Manufacturing Chemist
December 3, 2019
R. Jude Samulski: Gene Therapy’s Guiding Force
Pharmaceutical Executive
November 9, 2019
Triangle Life Science Exec Sheila Mikhail Shines as ‘Northstar’ Award Winner
WRAL TechWire
October 24, 2019
Cover Story: AskBio’s Tumultuous Ride to Achieve Unicorn Status
Triangle Business Journal
July 09, 2019
Top 10 Gene Therapy Companies in 2019
Proclinical
June 06, 2019
Meet Sheila Mikhail, Co-Founder of AskBio
Medium
May 28, 2019
How This Promising Gene Therapy for a Rare Neuromuscular Disease Was Fueled by Passionate Parents and a Dog
Genetic Literacy Project
May 7, 2019
AskBio Gets $235 Million in Gene Therapy Support
WRAL TechWire
April 12, 2019
AskBio Banks $235 Million Investment To Accelerate Growth
Triangle Business Journal
April 11, 2019
TPG, VIDA Back AskBio in $235 Million Round
BioCentury
April 11, 2019
AskBio’s $235 Million Financing Provides Clues to the Direction of Gene Therapy Investment
STAT
April 11, 2019
M&A Wrap
Mergers & Acquisitions
April 11, 2019
AskBio Reels in $235M to Ramp Up Gene Therapy Clinical Trials, Manufacturing
FierceBiotech
April 11, 2019
Jude Samulski Named to North Carolina Power 100
Business North Carolina
January 29, 2019
Let’s connect at an upcoming event. Check out the conferences and events we are attending and where we are speaking.
Upcoming Events
OCT Southeast 2020 | Research Triangle Park, NC
OCT Southeast 2020 has been postponed. Stay tuned for new dates.
Meeting on the Med 2020 | Barcelona
Meeting on the Med 2020 has been canceled. It will be held April 7-9, 2021 in Barcelona.
Advanced Therapies Congress 2020 | London
Join AskBio Europe President David Venables on for his presentation “Maximizing Value from the Expression Cassette in Gene Therapy Product Design.”
Past Events
Gene Therapy in Edinburgh
This meeting has been postponed. A new date has not yet been scheduled.
2020 MDA Clinical & Scientific Conference | Orlando
This meeting has been postponed. A new date has not yet been scheduled.
CED Venture Connect 2020
CED has postponed the Venture Connect conference and will reschedule this event for a later date in 2020.
11th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals | Lisbon
Join David Favre, VP Translational Medicine, for “AAV Immunogenicity: Novel Vectors & New Questions” on Feb. 18, 10am.
Alliance for Regenerative Medicine (ARM) | 2020 Cell & Gene Therapies State of the Industry
AskBio CEO Sheila Mikhail joined gene therapy leaders for the Next-Generation Gene and Cell Technologies panel. [Video]
Springboard Enterprises’ 13th Annual Winners’ Circle Dinner
AskBio CEO Sheila Mikhail was recognized at Springboard Enterprises’ 13th Annual Winners’ Circle Dinner, as the 2019 Northstar honoree.
Chardan Genetic Medicines Conference
AskBio CEO Sheila Mikhail presented at the 3rd annual Chardan Genetic Medicines Conference in New York.
Cell & Gene Meeting on the Mesa
Sheila Mikhail, CEO, of AskBio presented our differentiating capabilities, technology and therapeutic pipeline.
National Limb Girdle Muscular Dystrophy Conference
Joy Carson and Sharon Hesterlee, joined patients, families and leading stakeholders at the first-annual National Limb Girdle Muscular Dystrophy Conference in support of the LGMD patient community in Chicago.
Parent Project Muscular Dystrophy, 25th Annual Conference
AskBio’s Jude Samulski and Sharon Hesterlee joined the 25th Parent Project Muscular Dystrophy in Orlando.
Gene Therapy Panel (Alliance for Regenerative Medicine)
AskBio’s Andy Holt, VP Business Development & Manufacturing, participated on the gene therapy panel at the Alliance for Regenerative Medicine meeting held in April 2019. [Video]
The Growing Promise of Gene Therapy Approaches
Josh Grieger, PhD, Chief Technology Officer at AskBio, presented “The Growing Promise of Gene Therapy Approaches” at an NIH-hosted meeting. [Video]
Media Inquiries
We take pride in our relationships with media representatives. Our scientific experts are always available if needed for interviews and their insights.
Media Contact:
Robin Fastenau, Vice President, Communications
